Cellcolabs secured $12 million in primary funding from Titian Capital in Dubai
19 October 2025
19 October 2025
Total investments received (USD): 32.09M
Round value (USD): 12M
Round investors: Titian Capital
Company: Cellcolabs
Industry: BiotechHealth services
Related deals
One-Carbon Therapeutics raises SEK 153 million from new and existing investors in Sweden
Investments
05 November 2025
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain
United Kingdom